Advertisement: CJBS mid banner
Advertisement: RSM mid banner
Advertisement mid banner S-Tech 1
Advertisement: HCR mid banner
Advertisement: Mogrify mid banner
Mid banner advertisement: BDO
ARM Innovation Hub
Barr Ellison Solicitors – commercial property
Advertisement: EBCam mid banner
Advertisement: Simpsons Creative
Advertisement: Cambridge Network mid banner
Advertisement: partnersand mid banner
Advertisement: Kao Data Centre mid banner
6 December, 2017 - 10:52 By Tony Quested

Cambridge intel hothouse launches life science research team

IDTechEx, a Cambridge-based market intelligence company with nearly two decades of experience tracking cutting edge developments in science and technology, has expanded its expertise into the life sciences.

The new venture has already led to the production of five new dedicated market research reports in the key fields of biosensors, bioelectronics, and regenerative medicine. 

IDTechEx’s team of life sciences experts includes technology analysts Dr Alexis Karandrea, Dr David Pugh, Dr Laura Baers and Dr Nadia Tsao. 

With diverse but complementary backgrounds, the team is already developing additional new reports on synthetic biology, wound care technologies and bioelectronic medicine docketed for a spring 2018 release. 

The fresh capability adds to the already wide-ranging portfolio of engineering-based specialties covered by the company, including RFID, printed electronics, and energy storage. Previous topics like wearable technology and stretchable/conformal electronics have also covered developments in healthcare and medicine.

Raghu Das (pictured above), CEO of IDTechEx, said: “We’re excited to expand the offerings to our clients by applying our methodology and global analysis to the life sciences sector.

“It has many dynamics including broad academic and commercial technology research; strong market requirements due to the changing population demographics; player transformation with new smaller entrants bringing related technologies such as AI and connectivity in addition to traditional healthcare companies; and complex regulatory and territorial issues. 

“Our assessments of these issues provide clear analysis of the technologies and markets in life sciences.”

Many of these new topics have already been featured in IDTechEx events such as a show in Santa Clara in November. IDTechEx’s analyst team also delivered masterclasses on regenerative medicine, connected healthcare, and brain-computer interfaces. 

These were complemented by two conference session tracks, 3D Bioprinting and Sensors in Healthcare, highlighting breakthrough developments from leading companies in the field. 

A separate masterclass, Biosensors for Health Diagnostics, has been on the road this year at IDTechEx’s Business and Technology Insight Forums in Seoul, Tokyo, and Cambridge.

Newsletter Subscription

Stay informed of the latest news and features